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ABSTRACT 
Objective: Macrotyloma uniflorum (Horse gram) is an important legume widely consumed in the tropical south Asian countries including India. The 
present investigation is the elucidation of anti-inflammatory activity of M. uniflorum as it has several medicinal properties. The M. uniflorum was 
evaluated for inhibition of human secretory phospholipase A2 (sPLA2) as a function of anti-inflammatory activity.  
Methods: The total phenols, antioxidant (DPPH scavenging), Anti-lipid peroxidation, PLA2 inhibition and lipoxygenase (5 & 15-LOX) inhibition 
activity of aqueous extracts of M. uniflorum coat and pulp were assayed by in vitro method. The aqueous extract of M. uniflorum seed coat was 
subjected to inhibit PLA2 enzymes from human inflammatory fluids (Human Synovial Fluid and Human Pleural Fluid) and snake venoms (Naja naja 
and Vipera russllii) using [14]C labeled E. coli by in vivo method. A further effect of substrate and calcium concentration on inhibition of VRV-PLA2 in 
presence and absence of M. uniflorum coat extract were assayed. 
Results: Aqueous coat extract of M. uniflorum shows higher phenolics and biological activity and inhibited all sPLA2 enzymes in concentration dependent 
manner. The IC50 values are found to be in the range of 11.42-20.88μg and IC50 values for 5-LOX and 15-LOX is 25.92μg and 32.47μg respectively. The extract 
effectively neutralized indirect hemolytic activity and showed similar potency in neutralizing the in vivo sPLA2 induced mouse paw edema.  
Conclusion: These findings suggest that, the active compound/s in extracts of M. uniflorum individually or synergistically responsible for observed 
sPLA2 inhibition. 
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INTRODUCTION 
Inflammation is a localized reaction that produces redness, warmth, 
swelling and pain result in infection, irritation or injury. It 
contributes to all disease process including immunity, vascular 
pathology and leads to several undesirable consequences such as 
systemic shock, circulatory collapse and local tissue injury in many 
organs [32, 19]. Inflammation is mainly mediated by secretory 
phospholipase A2 (sPLA2). Several snake venom PLA2 (EC 3.1.1.4) 
enzymes are responsible for local tissue damage such as edema and 
hemorrhage. An elevated level of sPLA2 enzymes are detected in 
many inflammatory disorders [13, 14] and play a key role by 
releasing arachidonic acid and lysophospholipid, which are rate-
limiting precursors for the production of pro-inflammatory lipid 
mediators. Cyclooxigenase-1/2 (COX-1/2) and lipoxygenase (LOX) 
catalyze arachidonic acid into pro-inflammatory mediators such as 
prostaglandins, thrombaxanes, and leukotrienes respectively. 
Lysophospholipid is further converted into platelet activation factor 
(PAF) by acetyltransferase [29]. Further, phospholipase A2 (PLA2) 
plays a crucial role in a number of diverse cellular as well as 
chemical and metabolic injuries. Apart, they involved in 
phospholipid digestion and metabolism, host defense, signal 
transduction and provide precursors for eicosanoid generation. 
Present anti-inflammatory therapies include the non-steroidal anti-
inflammatory drugs (NSAIDs) that inhibit either Cyclo-oxygenase-
1/2 (COX-1/2) or Lipoxygenase (LOX) catalysis. The specific 
inhibitors of COX-1/2 and LOX enzymes have severe side effects 
such as intestinal ulceration, bleeding and cardiovascular 
complications [12]. In addition to these problems COX-1/2 or LOX 
inhibitors cannot regulate the production of leukotrienes or PAF 
that continue to cause inflammation [8]. It appears rational that 
effective inhibitors of sPLA2 could deplete the sources of arachidonic 
acid and, therefore, its downstream metabolites and PAF would not 
affect the homeostasis of COX-1/2 and LOX enzymes.  
Therefore, the great demand for natural products for PLA2 inhibition 
rather than NSAIDs to treat inflammatory disorders. The literature 
survey showed that several endogenous and exogenous agents have 
been reported to inhibit sPLA2 enzymes [31]. In addition, several 
laboratories are synthesizing compounds to inhibit sPLA2 [26]. But 
none of them are made into the market, which demands researchers 
to look for new specific sPLA2 inhibitors.  
Since a couple of years, the constant effort is made to bring out potent 
PLA2 inhibitors from a plant source. The aristolochic acid, lipoic acid, 
mangiferin, ellagic acid, genistein, oleanolic acid, ursolic acid, pongamia, 
anisic acid, ascorbic acid and derivatives of tricyclic dipyrido diazepin 
one, ascorbic acid, lipoic acid are evaluated for PLA2 inhibition from our 
laboratory [31, 26, 10, 11]. The present study, the legumes are a very 
interested source to identify/isolate the bioactive molecules for sPLA2 
inhibition. The legumes are nutraceuticals provide both nutrients as well 
as pharmaceuticals. Among legumes, Macrotyloma uniflorum (Horse 
gram) is an important legume, highly consumed/used in Asian countries. 
The few metabolites from M. uniflorum have shown the ability to 
interfere with the complex network of biochemical pathways connected 
to inflammatory processes [25]. The M. uniflorum is reported that 
protective effect on hyper uricemic and nephrotoxicity, diuretic, increase 
appetite, remove stone from kidney, cure hiccough, eye troubles, piles, 
enlargement of the spleen, pain in the liver, menstrual derangements, 
Antihepatotoxic activity [28], Anti-tumor efficacy [20], anti-themintic 
activity [24], hemolytic activity [16] and hepatoprotective activity[21]. 
Therefore, the M. uniflorum is selected for the present study.  
MATERIALS AND METHODS 
Materials 
14C-oleic acid was obtained from Perkin Elmer Life Sciences Inc. 
Boston, MA, USA. Fatty acid-free bovine serum albumin (BSA) fraction 
V was purchased from PAA Laboratories, GmbH Haidmannweg, 
Austria. Scintillation cocktail (Ultima Gold) was obtained from Packard 
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Bioscience, USA. Escherichia coli [lyophilized cells of strain W (ATCC 
9637)], Diphenyl Picryl Hydrazyl radical (DPPH˙), thiobarbituric acid, 
gallic acid, Dimethyl sulphoxide (DMSO) were purchased from Sigma-
Aldrich Chemical Laboratories, St. Louis, MO, USA. Human pleural fluid 
and synovial fluid were obtained from Chest Disease Hospital 
(Sanitorium), Mysore and Dr. Hegde’s Orthopedic Clinic, Mysore, India. 
Lyophilized powder of snake venoms (Naja naja and Vipera russllii) 
were purchased from Hindustan Park, Kolkata and Irula Co-operative 
Society Ltd., Chennai, India. The legumes were purchased from local 
provision store, Mysore, India. Swiss Wister mice weighing 20-25 g 
were obtained from Central Animal House Facility, University of 
Mysore, India. Ethical committee approved the use of laboratory 
animals (sanction order No: UOM/IAEC/38/2011). Animal care and 
handling were conducted in compliance with the national regulations 
for animal research. All other chemicals and reagents used in this 
study were of analytical grade or better. 
Methods  
Preparation of extracts and phytochemical analysis 
The good quality M. uniflorum seeds were purchased from local 
provision store; cleaned and soaked overnight. Then the seed coat 
and pulp were separated manually, air-dried and pulverized in 
classical method. The powder of coat and pulp (75g each) were 
packed in Whatman No.1 filter paper and subjected to soxhlet 
extraction with organic solvents such as hexane, benzene, 
chloroform-acetone, ethanol, methanol and water in the ratio of 
75g/500 ml (w/v). The extracts of organic solvents were 
concentrated to powder by flash evaporator, and water sample was 
reduced to powder by lyophilization. The yield was calculated and 
expressed as % w/w. The phytochemical analysis of different 
solvent extracts of M. uniflorum was done by methods described in 
Talari Samatha et. al [36]. The concentration of total phenolics and 
tannins in M. uniflorum extracts were estimated by the methods of 
Singleton [27] and Makkar [33] respectively. 
Estimation of antioxidant activity  
Antioxidant activity of M. uniflorum was determined using 2, 2-
Diphenyl-1-picryl hydrazyl radical (DPPH˙) as described by Blios [4]. 
Briefly, 100µg extracts of M. uniflorum (coat & pulp) were mixed 
with 5 ml of 0.1 mM methanolic solution of DPPH and incubated at 
20° C for 20 min in the complete dark. The control was prepared as 
above without extract and methanol was used for the baseline 
correction. Change in the absorbance of the samples was measured 
at 517 nm. Radical scavenging activity was expressed as percentage 
activity using the following formula. 
 
Lipid peroxidation activity 
Lipid peroxidation activity was estimated according to Buege JA et al 
[6]. The albino Swiss Wister strain rat’s perfused liver was isolated, 
and 10% (w/v) homogenate was prepared using a potter elvehjam 
homogenizer under ice cold (0-4°C) condition. The homogenate was 
centrifuged at 1,500 g for 5 min and clear supernatant was used for 
lipid peroxidation activity. The M. uniflorum extract (100µg) was 
mixed with 1.0 ml of 0.15M KCl and 0.5 ml of rat liver homogenate. 
The peroxidation assay was initiated by adding 100 µl of 0.2 mM 
ferric chloride. The reaction mixture was incubated at 37°C for 30 
min and the reaction was stopped by adding 2 ml of ice-cold HCl 
(0.25N) containing 4% TCA and 0.38% TBA. The reaction mixture 
was heated at 80° C for 60 min. The samples were cooled and 
centrifuged; the absorbance of the supernatant was measured at 532 
nm. An identical experiment was performed in the absence of 
extract to determine the amount of lipid peroxidation obtained in 
the presence of inducing agents. The anti-lipid peroxidation activity 
(ALP) is expressed as % ALP by using the following formula:  
% ALP = 1-sample absorbance/control absorbance X 100 
Phospholipase A2 assay  
The secretory PLA2 from human synovial fluid (HSF) and human 
pleural fluid (HPF) was purified by the modified method as 
described by Vishwanath et al., [34]. The sPLA2 activity will be 
measured using [14]C-oleate labeled autoclaved E. coli [22]. The 
reaction mixture 350 µl contained 100 mM Tris-HCl buffer (pH 7.4), 
5 mM calcium and 3.18 x 109 autoclaved E. coli cells (corresponds to 
10,000cpm and 60nM lipid phosphorus). The reaction components 
will be mixed in the following order: buffer, calcium, enzyme, and 
water. The reaction will be initiated by adding 30 µl of E. coli substrate 
and incubated at 37°C for 60 min. The reaction will be terminated by 
adding 100 µl of 2N HCl and 100μl of fatty acid-free BSA (10%) to 
entrap free fatty acids released. The tubes are vortexed and 
centrifuged at 20,000 g for 5 min. An aliquot (140 µl) of supernatant 
containing released [14]C-oleic acid is mixed with scintillation cocktail 
and [14]C radiation will be measured in Packard Scintillation analyzer. 
Enzyme activity will be expressed as a number of moles of free fatty 
acid released/min/mg of protein at 37° C.  
Inhibition of sPLA2 activity 
The reaction mixture 350 µl contained 10 mM Tris-HCl buffer pH 
7.4, 5 mM calcium and the amount of protein (PLA2 enzyme) was 
chosen such that 60-70% hydrolysis of substrate. Inhibition was 
carried out by adding aqueous coat extract of M. uniflorum in 0-75µg 
(w/v). The reaction was initiated by adding 30 µl of E. coli substrate 
and incubated at 37oC for 60 min. Oleanolic acid, a known inhibitor 
of PLA2 is used as the positive control. IC50 concentration of extract 
was calculated using software ‘GraphPad version 5.0 USA’. 
Effect of substrate and calcium concentration on sPLA2 
inhibition 
The total reaction mixture of 350 µl containing VRV-PLA2 alone and 
with IC50 concentration of aqueous coat extract of M. uniflorum in 
100 mM Tri-HCl buffer, pH 7.4 and 5 mM calcium. Substrate-
dependent assay was carried by the addition of various 
concentration of substrate (20-120 nM) and the calcium-dependent 
assay was carried with calcium concentration ranging from 2.5-15 
mM. The assay was carried out as described above. 
Inhibition of 5-Lipoxygenase  
The Poly Morpho Nuclear Leukocytes (PMNLs) 5-lipoxigenase (5-
LOX) assay was performed according to the method published by 
Aharony and Stein [1]. 1 ml of standard reaction mixture contained 
100 mM phosphate buffer pH 7.4, 50µg of DDT, 200µg of ATP, 300µg 
of CaCl2, 150µg of arachidonic acid and PMNLs lipoxygenase (5µg). 
The reaction was carried out at room temperature. Absorbance was 
read for every 30 seconds up to 2 min at 234 nm using Shimadzu 
spectrophotometer. The enzyme activity was expressed as µgole of 
5-HETE formed/min/mg protein. The 5-lipoxigenase was subjected 
to the inhibition by aqueous M. uniflorum coat extract. The 
Quercetin, a known inhibitor of LOX was used as a positive control. 
Inhibition of 15-lipoxygenase 
The enzyme assay was performed according to the method of 
Axelrod [3]. The standard reaction mixture for the 15-LOX assay (1.0 
ml final volume) contained 100µg linoleic acid and soybean 15-
lipoxygenase enzyme (5µg) in 200 mM borate buffer (pH 9.0). The 
reaction was carried out at room temperature. The absorbance was 
measured continuously for 3 min at 234 nm. The enzyme activity 
was expressed as µgole of 13-HPODE formed/min/mg protein. For 
inhibition study, different concentrations of extract were pre-
incubated with 15-LOX for 5 min. The reaction was initiated by 
adding linoleic acid to respective assay mixtures. Quercetin, a known 
inhibitor of LOX, was used as a positive control. 
Neutralization of indirect hemolytic activity 
The indirect hemolytic activity of M. uniflorum was measured as 
described by Boman and Kaletta [5]. The substrate was prepared by 
suspending 1 ml of packed fresh human RBC and 1 ml fresh hen egg 
yolk in 8 ml of PBS. Aqueous coat extract of M. uniflorum was pre-
incubated with 30µg of PLA2 for 30 min at 37°C. The substrate (1 ml) 
was added to the pre-incubated sample and allowed to react for 45 
min at 37 °C. The reaction was stopped by adding 9 ml of ice-cold 
PBS and the suspension was mixed and centrifuged at 1,500 g for 20 
min. The released hemoglobin was read at 530 nm. The substrate 
with sPLA2 enzyme served as positive control. 
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Neutralization of edema-inducing activity 
The procedure of Yamakawa et al., [35] as modified by Vishwanath 
et al., [21] was followed. Mice weighing 20–25g were injected with 
5µg of PLA2 enzyme alone or mixed with different concentrations of 
M. uniflorum extract in a total volume of 20 µl saline into their 
intraplantar surface of the right hind footpad. The respective left 
footpad received 20 µl of saline or vehicle and served as controls. 
The mice were sacrificed after 45 min by giving anesthesia 
(Pentobarbitone, 30 mg/kg, i. p.) and both hind limbs were removed 
at the ankle joint and weighed individually. The increase in weight 
due to edema is expressed as the ratio of the weight of edematous 
limb to the weight of normal (sham injected) limb × 100. Percentage 
increase of sham-injected control compared to the uninjected limb. 
Statistical analysis 
Inhibition percentage was calculated from the difference between 
extract/inhibitor treated group and control animals, which received 
the vehicle. Student’s t-test for comparisons of unpaired data was 
used for statistical evaluation. The experimental results were 
presented as mean±SD of three determinations. The IC50 
concentration was calculated using GraphPad version 5.0 USA. The 
statistical significance between different sPLA2s at a given 
concentration was analyzed by Duncan’s multiple range tests at 
P<0.05 using ANOVA of SPSS statistical software. 
RESULTS AND DISCUSSION 
The chemical substances and antioxidants derived from plants are 
potential interest in therapeutic intervention for chronic inflammatory 
disorders. They act either by inhibiting pro-inflammatory enzymes 
(PLA2, COX and LOX) or by inhibition of cytokines (IL-1β, TNF-α) 
release and inhibition of mast cell degranulation that are known 
contributors to chronic inflammatory disorders. The sPLA2 enzyme 
catalyze rate-limiting step in the production of pro-inflammatory 
eicosanoids and free radicals. The PLA2 catalyzed reaction is 
considered to be a significant pathway for reactive oxygen species 
(ROS) it turn activates PLA2 as well as lipid peroxidation and thereby 
augment the chronic inflammatory diseases to several folds [30]. 
Hence, the PLA2 inhibition is legitimate in the neutralization of 
inflammation. The antioxidants such as flavonoids, retinoids and 
vitamin E and their potential benefit in the intervention of 
inflammatory reactions arise if it inhibits the key enzyme PLA2 along 
with neutralizing the free radical generation reaction. 
The legume M. uniflorum is reported to have anti-inflammatory 
activity, but the mechanism is unclear. The PLA2 enzyme is subjected 
to inhibition as a function of anti-inflammatory activity. Initially, 
different solvent extracts of M. uniflorum were prepared and 
checked for VRV-PLA2 (Vipera russellii snake venom PLA2) 
inhibition. The aqueous extracts of M. uniflorum inhibit VRV-PLA2 to 
a greater extent (fig. 1a). Further, seed coat and pulp of M. uniflorum 
seed were separated, and the respective extracts are subjected to 
inhibition. The aqueous extracts of the seed coat and seed pulp 
inhibited the VRV-PLA2 to 87.56% and 52.1% respectively (fig. 1b). 
The total phenolics and antioxidant activity of extracts of M. 
uniflorum (100µg concentration) were estimated by Lowry's and 
DPPH methods respectively. The seed coat showed higher 
concentration of phenolics (83.4%) than pulp (30.2%). The seed 
coat showed 94.5% of anti-oxidant activity whereas pulp showed 
56.9%. The aqueous extract of coat showed anti-lipid peroxidation 
activity to 85.1% and pulp showed up to 60.8% (fig. 1b). The 
aqueous extract of seed coat inhibits VRV-PLA2 to the higher extent 
and it directly correlates to antioxidant activity and total phenolics. 
The phytochemical analysis of M. uniflorum showed that the ethanol 
and aqueous extracts contain higher concentration of flavonoids, 
alkaloids, tannins, saponins, phenols and quinones compared to non-
polar solvent extracts (table 1). The aqueous extract of seed coat 
showed a higher concentration of phytochemicals than pulp. The 
extracts were dialyzed and subjected for the antioxidant activity and 
anti-lipid peroxidation activity and it has nil activity for the same. 
To substantiate the potency of M. uniflorum coat extract, the 
secretory PLA2 enzymes from different sources were subjected to 
inhibition. The PLA2 enzyme NN-PLA2 from Naja naja snake venom 
and human PLA2s (HPF-PLA2 and HSF-PLA2) from Human Pleural 
Fluid (HPF) and Human Synovial Fluid (HSF) were checked. The 
seed coat extract inhibited entire sPLA2 enzymes at 60µg 
concentration in concentration dependent manner. The extent of 
inhibition was found to be>90% for HPF and HSF-PLA2;>80% for 
VRV-PLA2 and NN-PLA2 (fig. 2a). Percentage of inhibition varies 
significantly among the four different sPLA2 enzymes as tested by 
ANNOVA. Though sPLA2 enzymes exhibit more than 70% homology, 
many inhibitors inhibit these enzymes differentially due to 
differential binding affinities [14]. The IC50 values of coat extract for 
these sPLA2 ranges from 11.42-20.88μg (table 2) at 95% confidence 
limit. The oleanolic acid is taken for a positive control whose IC50 
values ranges from 3.08 to 7.78μg for those same PLA2 sources [10]. 
Since aqueous extract of M. uniflorum inhibited all sPLA2 enzymes 
taken up in this study. Further investigation was carried out with 
VRV-PLA2 enzyme to understand the mechanism of inhibition. 
Many inhibitors inhibit the sPLA2 activity either by binding to the 
substrate or by chelating the calcium. The steroid inducible sPLA2 
inhibitors, lipocortin I and II have shown to inhibit by non-specific 
binding and affecting the 'quality of interface' of membrane 
phospholipid [9]. Inhibition of VRV-PLA2 by aqueous extract of M. 
uniflorum (seed coat) was examined as a function of substrate 
concentration. The activity of VRV-PLA2 in the absence or presence 
of IC50 concentration of extract increases linearly with increasing 
substrate concentration. The maximal activity was observed with 
120 nmol of phospholipids. The percentage of inhibition was 
approximately 32% (fig. 3a) and remained constant over the entire 
range of substrate concentration used. 
 
 
Fig. 1: a) Inhibition of VRV-PLA2 by different solvent extracts of M. uniflorum. The 350 ml reaction mixture contained 5 mM Ca, 10 mM 
Tris-HCl buffer, 30 µl of substrate and extracts (100µg each). b) Estimation of total phenolics (% w/w), antioxidant activity, anti-lipid 
peroxidation and inhibition of PLA2 enzyme by aqueous extracts of M. uniflorum at 100µg. Data represents mean±SD (n=3) 
 
The possibility of PLA2 inhibition by aqueous extract is due to metal 
ion chelating was determined as a function of calcium concentration. 
PLA2 inhibition was checked by increasing calcium concentration 
from 2.5-15 mM. The VRV-PLA2 activity was increased linearly, but 
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did not change the extent of inhibition (fig. 3b). These data suggests 
that the active molecule/s present in the aqueous extract of M. 
uniflorum may inhibit sPLA2 directly and cause irreversible inhibition. 
The most NSAIDs target the either COX-1/2 or LOX enzymes or both 
the enzymes. Therefore, the aqueous extract of M. uniflorum was 
checked for the two of the inflammatory enzymes Poly Morpho 
Nuclear Lymphocytes LOX (PMNLs 5-LOX) and soybean LOX (15-
LOX). The activity of 5-LOX and 15-LOX was measured in terms of 
amounts of formation of 5-HETE and 13-HPODE respectively. The 
aqueous extract of M. uniflorum inhibited both the LOX enzymes in 
concentration dependent manner. IC50 values of extract of M. 
uniflorum coat for PMNLs 5-LOX and 15-LOX is 25.92μg (fig. 4a) and 
32.47μg (fig. 4b) respectively. 
The in situ hemolytic activity is an indirect way of measuring PLA2 
activity using egg yolk phospholipids dispersed as micelles together 
with washed erythrocytes. Aqueous extract inhibited the indirect 
hemolytic activity in concentration manner (table 3). Since, certain 
bioactive molecule/s might have bind to the enzyme irreversibly, the 
enzyme inhibition was irrespective of the nature of substrate 
provided for its activity. 
 
 
Fig. 2: a) Inhibition of different inflammatory PLA2 enzymes by aqueous extract of seed coat of M. uniflorum at different concentration. The 350 µl 
reaction mixture contained PLA2 enzymes (HSF-PLA2, HPF-PLA2, VRV-PLA2 and NN-PLA2), 5 mM Ca, 100 mM Tris-HCl buffer and M. uniflorum seed 
coat. b) Neutralization of sPLA2 (VRV-PLA2) edema-inducing activity by M. uniflorum coat extract. Data represents mean±SD (n=3) 
 
 
Fig. 3: Effect of substrate and calcium concentration on inhibition of VRV-PLA2 in the presence (□) and absence (■) of M. uniflorum coat extract. 
The reaction mixture contains VRV-PLA2 enzyme, 100 mM Tri-HCl buffer pH-7.4 and IC50 concentration of coat extract. Assay was carried by 
various concentration of a) substrate (20-120nM) and b) the calcium concentration (2.5-15 mM). Data represents mean±SD (n=3) 
 
 
Fig. 4: Inhibition of 5-LOX and 15-LOX by aqueous coat extract of M. uniflorum. 1 ml of reaction mixture contained, a) 100 mM phosphate 
buffer pH 7.4, DDT (50µg), ATP (200µg), CaCl2 (300µg), arachidonic acid (150µg) and 5-LOX (5µg). b) linoleic acid (100µg) and 15-LOX 
(5µg) in 200 mM borate buffer pH 9.0. Absorbance measured at 234 nm by µgole of 5-HETE and 13-HPODE formed/min/mg protein 
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Table 1: Photochemical analysis of M. uniflorum extracts 
Phytochemicals Hexane Benzene Acetone chloroform Methanol ethanol Aqueous 
pulp coat pulp coat Pulp Coat pulp coat pulp Coat pulp coat pulp Coat 
Tannins - - - - - - - - - + - + + + 
Saponins  - - - - - - - - + - + - + + 
Alkaloids  - - - - + + + + - + - + - + 
Phenolics  - + - + + + + + + + + + + + 
Terpenoids  - - - - - - - - - - - - + + 
Cardiac glycosides - - - - + + + + - + - + - - 
Flavanoids - - - - - - - - - - - + + + 
Anthraquinone  - - - - - - - - + - + - + + 
The different solvents extracts of M. uniflorum (both coat and pulp) were filtered decolorized using activated charcoal and dried using evaporator. 
The 100µg of extracts were re-dissolved in the respective solvents and used for analysis. (+) present; (-) absent 
 
Table 2: Inhibition of sPLA2 activity by coat extract of M. uniflorum 
Source of sPLA2 Specific activity* (nmol/mg/min at 37oC) IC50 (μg)# 
VRV-PLA2 148.0 11.42 
NN-PLA2 132.0 13.18 
HSF-PLA2 77.64 16.36 
HPF-PLA2 82.5 20.88 
*n moles of fatty acid released/mg of protein/min at 37 oC. #IC50 value is defined as the amount of inhibitors (µg) required to inhibit 50 % of enzyme 
activity in the given reaction mixture.  
 
Table 3: Inhibition of hemolytic activity of sPLA2 by coat extract of M. uniflorum 
Source of sPLA2 Hemolytic activity at different conc. of coat extract (μg) % of inhibition 
0 40 
NN-PLA2 92.5 31.5 61 
VRV-PLA2 90.58 24.8 65.78 
HPF-PLA2 95.5 24 71.5 
HSF-PLA2 93.94 28.6 65.34 
Aqueous extract of M. uniflorum was pre-incubated with 30µg of PLA2 for 30 min at 37 °C. The reaction is initiated by adding 1 ml substrate, 
incubated for 45 min at 37 °C and stopped by adding ice-cold PBS. Centrifuge at 1,500 rpm for 20 min, read the released hemoglobin at 530 nm. 
 
CONCLUSION 
The above data summarized that extract of M. uniflorum exhibited 
very good in vitro sPLA2 inhibition and in vivo anti-inflammatory 
activity by inhibiting edema induction in dose dependent manner. 
The sPLA2 inhibition by the aqueous extract is independent of 
calcium and substrate concentration. Significantly, the aqueous 
extract of M. uniflorum inhibited the pro-inflammatory enzymes like 
5-LOX and 15-LOX in concentration dependent manner. But, the 
extract used in the assay is crude there is always a possibility of 
cumulative effect which may be the other reason for sPLA2 
inhibition. However, several important questions remain open and 
further investigations are necessary to understand the mechanism 
underlying the effects of the extract and their active compound/s 
responsible for the anti-inflammatory activity.  
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